Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Clin Cancer Res. 2016 Nov 3;23(9):2325–2334. doi: 10.1158/1078-0432.CCR-16-1323

Figure 1. NNMT is a Prognostic Marker for GBM.

Figure 1

(A) The RNA-Seq data obtained from the cBioPortal shows the relative expression levels and mutational status of NNMT for a wide range of cancers including brain tumors.

(B) Representative tissue sections in TMA showing the NNMT staining in normal and GBM tissues.

(C–D) Protein and mRNA expression levels of NNMT in (C) primary and established GBM cell lines and (D) NNMT isogenic cell lines.

(E) Kaplan-Meier survival curves of NOD-SCID mice intracranially injected with NNMT isogenic cells.